The Discounted Cash Flow (DCF) valuation of Vifor Pharma AG (VIFN.SW) is 141.88 CHF. With the latest stock price at 166.15 CHF, the upside of Vifor Pharma AG based on DCF is -14.6%.
| Range | Selected | |
| WACC / Discount Rate | 4.4% - 6.7% | 5.5% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 82.04 - 855.63 | 141.88 |
| Upside | -50.6% - 415.0% | -14.6% |